Thursday, November 21, 2024 11/21/2024

Investigating the small peptide Tsr37, its role in virulence, and activation of the SaeRS two component system in Staphylococcus aureus

Award Number: R21AI156391
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Staphylococcus aureus is both a commensal of humans and a highly dangerous bacterial pathogen. S. aureus pathogenesis is mediated by a large repertoire of secreted and cell wall-associated virulence factors. To mount successful infections the bacteria must regulate expression of the genes encoding these virulence factors in a temporal and spatial manner. Two component signal transduction systems (TCS) are one type of regulatory circuit that bacterial cells use to sense their environment and modify gene expression accordingly. The Sae TCS is a global regulator of secreted protein production in S. aureus and a variety of well-studied virulence factors are known to be directly controlled by the Sae system. Activity of the Sae system is dependent on the balance between the kinase and phosphatase activities of the sensor protein SaeS. Human neutrophil peptide 1 (HNP-1) is known to activate SaeS kinase activity, while the Sae auxiliary proteins SaePQ induce phosphatase activity. Recent work in our laboratory has identified a potent, novel activator of the Sae system. Overexpression of the tsr37 gene in S. aureus results in a dramatic increase in Sae activity and upregulation of Sae target genes. In this proposal we will investigate the nature of the tsr37 gene product, investigate how tsr37 activates the Sae system, and determine the contribution of tsr37 to virulence. In addition, we will study the in vivo expression profile of tsr37 to determine when and where it is expressed during systemic infection. We anticipate that the results from this study will demonstrate that a short protein, Tsr37, acts as a potent activator of the Sae TCS. Understanding how a small peptide interacts with, and activates, the Sae system could inform future studies to design Sae inhibitors which could be used as a novel therapeutic to treat S. aureus infection.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$2,723 )
2024	2022	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Allergy and Infectious Diseases Research	000	2	8/29/2024	NON-COMPETING CONTINUATION	-$2,723
														Subtotal = -$2,723

Issue Date FY: 2022 ( Subtotal = $188,750 )
2022	2022	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Allergy and Infectious Diseases Research	000	2	2/2/2022	NON-COMPETING CONTINUATION	$188,750
														Subtotal = $188,750

Issue Date FY: 2021 ( Subtotal = $216,300 )
2021	2021	OHIO UNIVERSITY	1 OHIO UNIVERSITY	ATHENS	OH	45701	ATHENS	USA	Allergy and Infectious Diseases Research	000	1	3/15/2021	NEW	$216,300
														Subtotal = $216,300

Grand Total All Awards = $402,327

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating the small peptide Tsr37, its role in virulence, and activation of the SaeRS two component system in Staphylococcus aureus

Award Number: R21AI156391

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer